Page 36 - Biodegradable Polyesters
P. 36

14  1 Biodegradable Polyesters: Synthesis, Properties, Applications

                    Table 1.4 Thermal and mechanical properties of poly(glycolide) [21, 50].

                    Property                                       PGA
                       ∘
                    T ( C)                                          40
                     g
                       ∘
                    T ( C)                                        225–230
                     m
                             −3
                    Density(g cm )                                1.5–1.69
                    Tensile strength (GPa)                        0.08–1
                    Young’s modulus (GPa)                          4–14
                    Elongation at break (%)                       30–40
                    Applications Currently, polyglycolide and its copolymers (poly(lactic-co-glycolic
                    acid), poly(glycolide-co-caprolactone), and poly(glycolide-co-trimethylene car-
                    bonate)) are widely used as materials for the synthesis of absorbable sutures
                    [82–88]. In most cases, PGA is copolymerized with other organic acids such
                    as with PLA to make a PLA–PGA copolymer for improving its property [89].
                    PGA–PLA copolymers have been known to be biodegradable and histocom-
                    patible for the past 40 years. Their physicochemical and biological properties
                    have been found suitable, in many instances, for sustaining drug release in vivo
                    for days or months [89, 90]. Microencapsulation technique is chosen frequently
                    for its unique properties because microcapsules can be made using different
                    traditional and nontraditional techniques containing core materials ranging
                    from biological proteins to synthetic drugs [90]. Lima and Rodrigues Junior [91]
                    reviewed the development of a biocompatible delivery system using poly(-DL-
                    lactide-co-glycolide) microspheres as a controlled release antigen for parenteral
                    administration offers several advantages in terms of immune adjuvanticity over
                    other compounds. It was found that, in contrast to other carriers, microspheres
                    are more stable, thus permitting administration by the oral or parenteral route.
                      Nanotechnology has been applied in drug delivery system in recent years using
                    biodegradable polymer as key carrier materials. Biodegradable nanoparticles
                    formulated from biocompatible poly(D,L-lactide-co-glycolide) has shown the
                    potential for sustained intracellular delivery of different therapeutic agents
                    [92]. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres
                    attracted attention. For brain drug administration, locally controlled drug release
                    by way of an implantable polymeric device was developed as macroscopic
                    implants needing open surgery for implantation. To avoid surgery implantation,
                    poly(lactide-co-glycolide) microspheres were shown to be safe and promising
                    for drug delivery into the brain. Poly(lactide-co-glycolide) is biodegradable and
                    biocompatible with brain tissue. Owing to their size, these microspheres can be
                    easily implanted by stereotaxy in discrete, precise, and functional areas of the
                    brain without causing damage to the surrounding tissues. Brain tumor treatments
                    were developed using this approach [93]. Biodegradable nano/microparticles of
                    poly(DL-lactide-co-glycolide) and PLGA-based polymers are widely investigated
                    as carriers for controlled delivery of macromolecular therapeutics such as
                    proteins, peptides, vaccines, genes, antigens, and growth factors. These devices
   31   32   33   34   35   36   37   38   39   40   41